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MOLECULAR DYNAMICS SIMULATION OF IBUPROFEN CRYSTAL 
POLYMORPH 
 
ABSTRACT 
 
Ibuprofen (iso-butyl-propanolic acid) is one of the Active Pharmaceutical 
Ingredients (API) that uses to treat a symptom of rheumatism, arthritis, fever, as an 
analgesic (pain reliever). This study aims to identify which solvents should affect the 
polymorph of ibuprofen begins from the crystallization solution. The Molecular 
Dynamics Simulation and Fourier transform infrared (FTIR) is used to recognize which 
molecules that form hydrogen bond in the ibuprofen crystal polymorph. The study 
analysis has shown that the higher hydrogen bond between the atoms will contribute to 
the ibuprofen crystal polymorph. As the conclusion, only the selected atoms will 
contribute in the formation of desired crystal polymorph of ibuprofen.   
Keywords : radial distribution function, diffusion coefficient, hydrogen bonding 
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SIMULASI DINAMIK MOLEKUL IBUPROFEN KRISTAL POLIMORF 
 
ABSTRAK 
 
 Ibuprofen (iso-butil-propanolic asid) adalah  salah satu daripada Ramuan Aktif 
Farmaseutikal (API) yang digunakan untuk merawat gejala penyakit reumatisme, artritis, 
demam, sebagai analgesik (pelega kesakitan). Kajian ini bertujuan untuk mengenal pasti 
pelarut mana akan menjejaskan polimorf ibuprofen bermula dari larutan kristal. Simulasi 
Dinamik Molekul dan Jelmaan Fourier Inframerah (FTIR) digunakan untuk 
mengiktirafkan molekul yang membentuk ikatan hidrogen di ibuprofen Kristal polimorf. 
Analisis kajian telah menunjukkan bahawa hidrogen yang lebih tinggi ikatan antara atom 
akan menyumbang kepada ibuprofen  kristal polimorf. Sebagai kesimpulan, hanya atom 
yang dipilih akan menyumbang dalam pembentukan diingini kristal polimorf ibuprofen. 
Katakunci: fungsi agihan jejarian, pekali resapan, ikatan hidrogen 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
 In this chapter, its cover why the ibuprofen is used as the main element in the 
active pharmaceutical ingredients for the research. In this chapter also cover what are the 
problems in the pharmaceutical industry and to be specified the problem in the 
crystallization of ibuprofen polymorph. Besides that, the chapter will cover all the 
objectives in this study and what are the significances of this study toward our future 
development in the pharmaceutical sector. 
 
 
1.1 Background of Study 
 
 Ibuprofen is one of the famous active pharmaceutical ingredients (API) in the 
current pharmacy industry. Ibuprofen or iso-butyl-propanoic phenolic acid is of being a 
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well known drug that used to treat a symptom of rheumatism, arthritis, fever, as an 
analgesic (pain reliever), especially where there is an inflammatory component and 
dysmenorrhea. It is also applicable to use for pericarditis and patent ductus arteriosus ( 
Derksen, 1995). Ibuprofen is a common non-steroidal anti-inflammatory drug (NSAID). 
NSAID can be described as the drugs with analgesic and antipyretic (fever reducing) 
effects and which have higher dose anti-inflammatory effects. Besides that, the ibuprofen 
is known to have an effect of antiplatelet, though it is relatively mild and somewhat short-
lived if compare with others API such as aspirin and others better known antiplatelet 
drugs. Aspirin breaks down in the solution which completely different with the ibuprofen. 
Ibuprofen in which state is stable and that makes the ibuprofen available in the topical gel 
form thus can be absorbed by the skin, and can be used for the sports injuries that 
theoretically have the least risk of digestion problem. Besides this properties of the 
ibuprofen, ibuprofen is classified as an important part or core in the medicine of the 
World Health Organization’s” WHO Model List of Essential Medicines”, which is a list 
of minimum medical needs for basic health care system (Kouimtzi, 2009).  
 
  
1.2 Problem Statement 
 
 Polymorphism and solvate formation represents a major issue in pharmaceutical 
crystallization to the pharmaceutical industry and in terms of patent establishment and 
protection, reliability of production, and stability on storage and in processing. So, it is 
very compulsory to study the method in order to solve the problem in the pharmaceutical 
crystallization. Different types of solvent used will affect the interaction between the 
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solute-solvent and how do solute-solvent interactions to reflect the polymorphism due to 
the different solubility. The chosen of solvent also will be considered in this research for 
the ibuprofen crystal polymorph. 
 
 
1.3  Research Objectives 
 
 This study aims to identify which solvent should affect the polymorph of 
ibuprofen begin with the crystallization solution and to investigate the correlation between 
the intermolecular forces of the molecules by the radial distribution function and 
hydrogen bond existing in the structure. 
 
 
1.4  Research Questions/Hypothesis 
 
 The research question in this study is to identify which solvent will affect the 
polymorph of ibuprofen by the crystallization solution and to relate between inter-atomic 
distances between specified atoms in solute molecules that is ibuprofen. 
 
 
1.5  Scope of Study 
 
 The study covers the research by the molecular dynamics simulation and by the 
experimental analysis. The molecular dynamics simulation consists of 2 systems which 
pure and binary system at 298.15K.  It is will include the system for ethanol and ethyl 
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acetate. For the experimental analysis, the study will cover by the molecular recognition 
by using the Fourier transform infrared (FTIR) for the ethanol, hexane and ethyl acetate at 
saturated solution at 298.15K. 
 
 
1.6  Expected Outcome 
 
 The expected outcome of this study is to clearly understand on how the solute-
solvent interaction influences the crystallization by the analysis through the experimental 
study and also through a simulation study. Another outcome predicted is how the different 
solvent used affects the solubility of an ibuprofen by study of experiment and by the 
simulation. 
 
 
1.7  Significance of Study  
  
 There are 4 significance of this study which towards our medical, engineering, 
economics and environment. For the medical aspects, the efficiency of the drug depends 
on its solubility which strongly influence by the choice of crystal structure used in 
processing the drug. For the second aspect which the engineering aspect, this study will 
able fully understand the correlations in the inter-atomic distances between specified 
atoms in solute molecules by determine the of Radial Distribution Function (RDF). And 
in the economic aspect, by using the molecular dynamic simulation all the new therapies 
and to develop the existing one can only be done by using the molecular dynamic 
simulation since the price for the active pharmaceutical ingredients is expensive. 
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Meanwhile, in the environmental aspect, the simulation will prevent the dispose of 
hazardous waste to the environment.  
 
 
1.8  Conclusion 
 
 At the conclusion, in this chapter able to identify why this study has been 
proposed and what is the problem with this study. All the scope of study must fully cover 
in order to achieve our objective in this study and what will it’s done towards our future in 
terms of medical, engineering, economics and environment.  
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CHAPTER 2 
 
 
LITERATURE REVIEW 
 
 
2.1  Introduction 
 
 This chapter is the review of previous research on the related topic with this study 
and by this literature review, helps fully understand that study that had been done and also 
the problem that current researcher try to solve for the benefit of the human kind and also 
all the living things in the earth. One of the objectives of this chapter is to understand the 
full concept and ideas about the ibuprofen, crystallization, active pharmaceutical 
ingredients (APIs), dynamic simulation and also all the aspects related to the topic of 
research. It will explain the application of the ibuprofen in the current pharmacy industry 
and also the important aspect that need to be considered in the producing the crystal 
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ibuprofen. Besides that, it will also explain about the polymorphism also for the 
ibuprofen. 
 
 The literature review is done based on the journals that are related ibuprofen 
crystal polymorph and also the dynamic simulation of it. The literature review will cover 
the characteristic of ibuprofen. This chapter will also cover the active pharmaceutical 
ingredients (APIs). The software used in the simulation also will be considered to gain the 
most accurate result for the simulation of the compound. This chapter will let the reader 
know the importance of ibuprofen. The concept of crystallization method used in obtains 
the crystal structure of ibuprofen. 
 
 
2.2  Crystallization 
 
Crystal that obtains from the solution by the process called crystallization, 
Crystallization is a procedure used in the chemical industries for the preparation of the 
many types of solid (e.g. pharmaceutical products, chemical intermediates, specialty 
chemicals, catalyst) (Micheal et al. 2008) and it’s widely used for the purification of drugs 
during the final stages of the process under the pharmaceutical products industries 
(Garekani and Sadeghi, 2001). Many drugs exist in the crystalline solid form because of 
the stability and ease handling during the various stages of the process and development. 
Crystalline solid can appear in the form of polymorph, solvates or hydrates (Jacob et al. 
2011). Several key properties of the resultant materials originate from this process, 
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including chemical purity and composition, internal structure (polymorph state), size and 
shape distribution and detect density (crystallinity).  
 
It is very significant to control the crystal form of the drug during the different 
stages of process because any phase changes due to the polymorph interconversions, 
desolvation of solvates, formation of hydrates and changes in the degree of crystallinity 
can alter the bioavailability of the drug. The solid drug may experience a change in the 
thermodynamic properties during the phase transition, with consequent changes in the 
transport characteristics and its dissolution (Vippagunta et al. 2001). The solvent use will 
have a larger impact on the resulting morphology by the process crystallization but the 
consistent prediction not yet can be determined (Horst et al. 2001). Even the chemical 
composition of the crystalline polymorph is the same but it gives different in the internal 
crystal structures and therefore, posses’ different physic-chemical properties (Borka and 
Haleblian, 1990). 
 
Few models exist for predicting the morphology of crystal grown from solution.  
The solvent - crystal interface of the molecular level simulation have been successfully 
used to predict the shapes of several organic crystal systems. This method makes us use of 
pure solvent properties and does not require molecular level fluid-phase simulations for 
designing solvents for crystallization process that related to the hydrogen bonding 
solubility parameter of solvent and crystal morphology that resulting the desire crystal 
polymorph (Acquah et al. 2008). And for this study, the researcher has already 
highlighted the solvent as the parameters in the crystallization process since they solvents 
play a significant role in the crystalline of the solid. 
 
 
9 
 
 
 
2.1.1  Crystallization of Active Pharmaceutical Ingredients (APIs) 
 
 Active pharmaceutical ingredients (APIs) are defined as the any substance or 
combination of substances used in a finished pharmaceutical product, intended to furnish 
pharmacological activity or otherwise have direct effect in the diagnosis, cure, mitigation, 
treatment or prevention of disease or to have a direct effect in restoring, correcting or 
modifying physiological functions in- human beings . It is frequently delivered to the pa-
tient in the solid-state as part of the approved dosage form (e.g. tablets, capsules, etc..) 
and each form will display a unique physicochemical properties that can profoundly influ-
ence the bioavailability, manufacturability purification, stability and other performance 
characteristics of the drug ( Sherry and Matthew, 2003). Advances in the pharmaceutical 
sciences have shown and significant impact in the increasing of the number of approaches 
for addressing the issues of low aqueous solubility. These strategies for improving and 
maximize the dissolution rate include micronisation to produce higher surface area for 
dissolution, the use of salt forms with enhanced dissolution profiles, solubilisation of 
drugs in co-solvents and micellar solutions, complexation with Cyclodextrins and the use 
of lipid systems for the delivery of lipophilic drugs ( Blagden and Matas, 2007). 
 
Many compounds of pharmaceutical interest have the ability to exist in more than 
one crystal structure or crystalline form. The commonest crystal forms are polymorph and 
solvates, that the different polymorph will have a differential in the internal crystal 
structure and therefore possess different physicochemical properties (Jacob et al. 2011). 
The differences of the properties make the crystal polymorph are difficult to control in 
